This Article Full Text Full Text (PDF) All Versions of this Article: 111/1/21    most recent 01.CIR.0000151291.32974.D5v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sidhu, J. S. Articles by Roberts, R. Search for Related Content PubMed PubMed Citation Articles by Sidhu, J. S. Articles by Roberts, R. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide OMIM Protein UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB ADENOSINE 5'-PHOSPHATE Genetics Home Reference Related Collections Electrophysiology Clinical genetics Animal models of human disease Physiological and pathological control of gene expression

(Circulation. 2005;111:21-29.)
© 2005 American Heart Association, Inc.

Arrhythmia/Electrophysiology

Transgenic Mouse Model of Ventricular Preexcitation and Atrioventricular Reentrant Tachycardia Induced by an AMP-Activated Protein Kinase Loss-of-Function Mutation Responsible for Wolff-Parkinson-White Syndrome

Jasvinder S. Sidhu, MD; Yadavendra S. Rajawat, MD; Tapan G. Rami, MD; Michael H. Gollob, MD; Zhinong Wang, MD, PhD; Ruiyong Yuan, MD; A.J. Marian, MD; Francesco J. DeMayo, MD; Donald Weilbacher, MD; George E. Taffet, MD; Joanna K. Davies, PhD; David Carling, PhD; Dirar S. Khoury, PhD; Robert Roberts, MD

From Baylor College of Medicine (J.S.S., Y.S.R., T.G.R., Z.Q., R.Y., A.J.M., F.J.D., D.W., G.E.T., D.S.K.), Houston, Tex; University of Ottawa Heart Institute (M.H.G., R.R.), Ottawa, Ontario, Canada; and Imperial College (J.K.D., D.C.), London, England.

Correspondence to Robert Roberts, MD, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, Ontario, Canada K1Y 4W7. E-mail rroberts{at}ottawaheart.ca

Received June 17, 2004; revision received September 1, 2004; accepted September 13, 2004.

Background— We identified a gene (PRKAG2) that encodes the -2 regulatory subunit of AMP-activated protein kinase (AMPK) with a mutation (Arg302Gln) responsible for familial Wolff-Parkinson-White (WPW) syndrome. The human phenotype consists of ventricular preexcitation, conduction abnormalities, and cardiac hypertrophy.

Methods and Results— To elucidate the molecular basis for the phenotype, transgenic mice were generated by cardiac-restricted expression of the wild-type (TG_WT) and mutant(TG_R302Q) PRKAG2 gene with the cardiac-specific promoter -myosin heavy chain. ECG recordings and intracardiac electrophysiology studies demonstrated the TG_R302Q mice to have ventricular preexcitation (PR interval 10±2 versus 33±5 ms in TG_WT, P<0.05) and a prolonged QRS (20±5 versus 10±1 ms in TG_WT, P<0.05). A distinct AV accessory pathway was confirmed by electrical and pharmacological stimulation and substantiated by induction of orthodromic AV reentrant tachycardia. Enzymatic activity of AMPK in the mutant heart was significantly reduced (0.009±0.003 versus 0.025±0.001 nmol · min^–1 · g^–1 in nontransgenic mice), presumably owing to the mutation disrupting the AMP binding site. Excessive cardiac glycogen was observed. Hypertrophy was confirmed by increases in heart weight (296 versus 140 mg in TG_WT) and ventricular wall thickness.

Conclusions— We have developed a genetic animal model of WPW that expresses a mutation responsible for a familial form of WPW syndrome with a phenotype identical to that of the human, including induction of supraventricular arrhythmia. The defect is due to loss of function of AMPK. Elucidation of the molecular basis should provide insight into development of the cardiac conduction system and accessory pathways.

Key Words: Wolff-Parkinson-White syndrome • genetics • tachycardia

This article has been cited by other articles:

				L. H. Young AMP-Activated Protein Kinase Conducts the Ischemic Stress Response Orchestra Circulation, February 12, 2008; 117(6): 832 - 840. [Full Text] [PDF]

				M. H. Gollob Modulating Phenotypic Expression of the PRKAG2 Cardiac Syndrome Circulation, January 15, 2008; 117(2): 134 - 135. [Full Text] [PDF]

				K. D. Folmes, L. A. Witters, M. F. Allard, M. E. Young, and J. R. B. Dyck The AMPK {gamma}1 R70Q mutant regulates multiple metabolic and growth pathways in neonatal cardiac myocytes Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3456 - H3464. [Abstract] [Full Text] [PDF]

				P. Charron, M. Genest, P. Richard, M. Komajda, and G. Pochmalicki A familial form of conduction defect related to a mutation in the PRKAG2 gene Europace, August 1, 2007; 9(8): 597 - 600. [Abstract] [Full Text] [PDF]

				M. Arad, C. E. Seidman, and J.G. Seidman AMP-Activated Protein Kinase in the Heart: Role During Health and Disease Circ. Res., March 2, 2007; 100(4): 474 - 488. [Abstract] [Full Text] [PDF]

				V. W. Dolinsky and J. R. B. Dyck Role of AMP-activated protein kinase in healthy and diseased hearts Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2557 - H2569. [Abstract] [Full Text] [PDF]

				J. Li, D. L. Coven, E. J. Miller, X. Hu, M. E. Young, D. Carling, A. J. Sinusas, and L. H. Young Activation of AMPK {alpha}- and {gamma}-isoform complexes in the intact ischemic rat heart Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1927 - H1934. [Abstract] [Full Text] [PDF]

				H. Yu, M. F. Hirshman, N. Fujii, J. M. Pomerleau, L. E. Peter, and L. J. Goodyear Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase {gamma}3-subunit differentially regulates glycogen accumulation Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E557 - E565. [Abstract] [Full Text] [PDF]

				J. R. B. Dyck and G. D. Lopaschuk AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol., July 1, 2006; 574(1): 95 - 112. [Abstract] [Full Text] [PDF]

				J. K. Davies, D. J. Wells, K. Liu, H. R. Whitrow, T. D. Daniel, R. Grignani, C. A. Lygate, J. E. Schneider, G. Noel, H. Watkins, et al. Characterization of the role of {gamma}2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1942 - H1951. [Abstract] [Full Text] [PDF]

				R. Roberts Genomics and Cardiac Arrhythmias J. Am. Coll. Cardiol., January 3, 2006; 47(1): 9 - 21. [Abstract] [Full Text] [PDF]

				F. Ahmad, M. Arad, N. Musi, H. He, C. Wolf, D. Branco, A. R. Perez-Atayde, D. Stapleton, D. Bali, Y. Xing, et al. Increased {alpha}2 Subunit-Associated AMPK Activity and PRKAG2 Cardiomyopathy Circulation, November 15, 2005; 112(20): 3140 - 3148. [Abstract] [Full Text] [PDF]

				L. Zou, M. Shen, M. Arad, H. He, B. Lofgren, J. S. Ingwall, C. E. Seidman, J. G. Seidman, and R. Tian N488I Mutation of the {gamma}2-Subunit Results in Bidirectional Changes in AMP-Activated Protein Kinase Activity Circ. Res., August 19, 2005; 97(4): 323 - 328. [Abstract] [Full Text] [PDF]